Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

CD4 cell 27
Abstract

SKeyword

Abstract--

Keyword

iral therapy normalizes
al resistance where no
ce in S.o Paulo, Brazil/
o flow cytometry based
sment of viral load and
Establishment of HeLa/
isease/Dynamics of
RT on HIV viral load and
-type specificity for the
implanted with human
ction of primary human
G antibodies binding to
nfection prior to AIDS/
of plasma HIV RNA on
s of HIV RNA levels and
ents/Plasma viral load,
nd add to viral load and
AP) for African settings/
marker of HIV disease/
o accurately predict the
a/Correlation between
cted patients with >400
ndian HIV population/
quality control study for
hod validation for HIV+
specific gene-modified
oad in HIV+ adults with
t-stable HIV+ men with
ted subjects with <100
f life, mood, coping and
/Viral detectability and
evalent cases based on
n plasma viral load and
V-infected patients with
sal HIV-1 viral load and
1-infected patients with
on HIV RNA levels and
s on viral load (VL) and
ortional inversely to the
+)/AIDS naive patients/
garia/Use of monitored
/Oral mucosal lesions,
1 patients with 50-250
equences expressed in
RV)-naive patients with
ases virus replication in
mparison of number of
mens according to initial
Whole blood Capcellia~
s on RNA viral load and
between viral load and

/CD8 ratio in HIV infected patients/Ear 32320
or RNA monitoring is available in Braz 33167
+ T lymphocytes counts of HIV infecte 33275
T-cell enumeration for absolute and p 41116
/CD8 ratio in blood and lymph nodes in 289*/41142

-LTR-~-Gal stably expressing CCR5 s
+ T cell recovery in a large cohort treat
T cells in the mucosa-associated lymp
binding site of HIV-1 gpl20/Characte
+ cells and challenged with HIV1/Pas
+ T-cells/Effective pseudotyping of ret
+ T-cells are a sensitive parameter to
+ cell decline despite maintenance of
change and outcome for women in th
counts when assessing all-cause mor
count and p24 antigenemia in HIV-inf
T cells as prognostic indicators/Plas
T cells phenotyping by flow cytometry:
5 activity in T cells: A new surrogate m
+ T-cell count in a group of HIV-1 -infec
/CD8 and total lymphocyte cell counts
cell count/Longitudinal study of CD8
counts as a surrogate marker in India
evaluation in HIV disease/The Italian
analysis transported to a central clinic
and CD8 T cells leads to improved T c
+ counts 200-499/mm3/Effects of aer
< 200 cells/mm3: CPCRA 038/Protei
+ lymphocytes/mm3/Nutritional suppl
levels/Effects of self-management tra
levels in patients receiving protease in
numbers at entry, with application to n
+ lymphocyte count as a response to tr
cells < 75/mm3: An updated decision
+ T cell subset in AIDS patients/Correl
+ T lymphocytes of 200/mm3/Chemok
counts in HIV positive subjects/The ef
count/Changing highly active antiretr. Report of 7 cases in a non-governme
marker of immune restoration in asso
cell counts: Predictions of the AIDS e
count, viral load and other covariates i
cells/mm3/Subgroup analysis of clinic
+ cells/Broad spectrum resistance to
counts of 20-300/mm3/A randomized
+ cells naturally or acutely infected by
+ cells to number of viral RNA copies i
count/Virological response to proteas
/CD8 immunoassay for enumeration o
T cells count/Quadritherapy including
count in patients with and without trea

41163
41179
41185
41233
41243
41245
42110
42152
42153
42159
42180
42181
42182
42183
42187
42189
42190
42194
42203
42205
42321
42328
42339
42347
42371
42403
43472
43473
43481
60122
60132
60159
60178
60222
60235
60237
60299
60358
60375
60397
60407
60721
60812
60818
60966
60991
12180
31171
31181
21125
21195
11220
12138
12184
12189
12215
12293
212*/21106
268*/21108
21130
274*/21159
275*/21164
217*/21171
495*/21192
21193
22345
109*/31121
601 */31122
31143
110*/31165
116*/31170
31171
32148
32320
289*/41142

rrelation between CD4/ and total lymphocyte cell counts to op 42189
t/Longitudinal study of T cell activation and viral load in HIV-i 42190
Us/The CD38 subset of cells predicts progression to AIDS in I 42191
ene-modified CD4 and T cells leads to improved T cell surviv 42321
ppress HIV replication/ + cells exposed to B7.2 but not B7.1 d 60406
nt/Inhibition of HIV-1 by + cells from seropositive individuals is 60414
n children/Changes in lymphocyte subset counts at different 60790
blood Capcellia~ CD4/ immunoassay for enumeration of the 60818
CPCRA004/ACTG177/ CDC /PAHO)/A randomized trial of rifampi 447*/22126
Lessons learned at the National AIDS Hotline/A decade of e 33295
Ilaborative networks of -funded community-based organizati 34338
1 RNA levels present in performance evaluation samples/Ev 42142
ssons learned from the African-American initiative: Keeping 43279
he invisible population: 's experience in correctional health ca 43408
xpression: High density cDNA analysis of HIV-1 infected cells/HIV- 21152
IV-infected children by length analysis of T cell receptor (T 212*/21106
D) clinics in Fortaleza, Ceara, northeast Brazil/Profile of the wom 23498
theater against AIDS in, northeast Brazil/Street theater agai 33461
V/AIDS/Treatment with cefixime on ideopathic mouth ulcers on pa 22331
V-1 in semen/Seminal cell-associated viral transcriptional activit 279*/11151
ma HIV-1 RNA level?/ls infectious HIV-1 viral load 13308
hedding of cell-free and HIV in semen/Influencing 23392
eudopeptide that binds cell-surface proteins/Specific inhibition of 41182
Vpr-induced cell death/ Cell cycle G2 arrest by HIV-1 Vpr is not res 11141
iving retroviral therapy/ fusion infectivity assay in patients rece 22407
acterium tuberculosis/ surface markers of immune activation 31184
s learned by NGO AIDS /Multiplicity of small interventions: Les 44295
V-1 in saliva and blood/ tropism, subtype, nucleotide diversity 60171
selected by passage in cell culture/Isolation of MIP-la-resistant 11110
ated HIV-1 genomes in culture by CpG methylation/lnactivatio 11127
ssion of HIV-infected T using high density oligonucleotide arra 380*/11139
onsible for Vpr-induced death/Cell cycle G2 arrest by HIV-1 V 11141
nsgenic for HIV-1 Vpr/T apoptosis in mice transgenic for HIV-1 11142
cted Macaques/Early T dysfunctions during acute infection of 11224
rognostic value of CD4 counts: The EuroSIDA study/Impact o 12106
/HIV serum RNA, CD4 numbers and risk for clinical endpoints 507*/12124
inical AIDS after CD4+ count falls below 200/pl/Predictive val 12133
ameroon/CD4+, CD8+ counts, CD4/CD8 ratio and clinical feat 12138
is markers/Endothelial dysfunction in HIV infection: relationsh 12139
apy (HAART)/Naive T subsets during acute infection (Al) with 12190
en/Viral load and CD4- count under a triple-therapy with nelfin 12256
ent/Changes in CD4+ count and the risk of opportunistic infe 12331
of antigen-specific CD4 function in HAART patients/Follow-up 12341
n of HIV replication and proliferation leads to minimal levels of 12371
HIV infection and CD4+ count in peripheral blood/HPV DNA in 13293
ok/Viral load and CD4 count in injecting drug users (IDUs) ne 191*/13302
ection drug users/CD4 count and viral load in HTLV-II and HIV 13326
ctive patterns of CD8 T clonal dominance identified in HIV-infe 212*/21106
ly infected primary Th2 s and cell lines/Triggering of CD30 enh 21153
Relationships between tropism spectrum, cytopathology pecu 21158
echanism of bystander death of CD8 T cells induced by CD4 c 274*/21159
ajor inducer of CD4+ T death in HIV-1-infected subjects: Inhibi 21160
cyte activation-induced death in primary acute infection/Expre 21161
tion with decrease in T activation markers/Therapy induced r 21163
ed apoptosis of CD4 T s from HIV+ patients is proportional to 21165
HIV therapy on T helper homeostasis and type 1 cytokine synth 219*/21169
ease/Alteration of intra ular cytokine synthesis in CD4+ and C 217*/21171
not SI viruses enhance proliferation and beta-chemokine prod 21175
ction analysed at single level during highly active antiretroviral t 221*/21176
s/HIV-infection alters T immune response to hepatitis C virus a 21182
n of macrophage and T line tropic viruses by a bivalenet subty 21214
viduals with stable CD4 count above 200/tL/Withdrawal of pri 22179
cules associated with B activation/The emergence of AIDS-as 22290
mics of mean TRF and T homeostasis during HAART/Dynamic 22341
rculating naive CD8+ T counts/Highly active antiretroviral ther 22345
n patients with low CD4 counts/Antiretroviral combination ther 22408
otic twins: Insight into T dynamics/Immune reconstitution of HI 272*/22411
A32/lncreased CD4+ T response to IL-2 therapy in HIV-1 -infec 22419
s/Depression and CD4 count as predictors of quality of life in H 24223
mphocyte counts and T function in long-term AIDS-free HIV-1 i 31109
d reduction of CD8+ T oligoclonality/Initiation of antiretroviral 109*/31121
Cross-clade cytotoxic T response to HIV-1 proteins among HL 602*/31128
on and HIV-1 specific T responses during highly active antiretr 113*/31134
be mediated by a CD8+ anti-HIV response/Protection of HIV-e 31143

hers/Strong cytotoxic T responses detected in the majority of u 31157
sociated with impaired function/Interleukin-8 receptor down-r 31167
8 and CD38 by CD8+ T s in HIV infection correlates with viral lo 116*/31170
using BC-3 and BCP-1 lines/Antibody response against HHV- 31195
ssion through epithelial barriers/Mechanisms of HIV transmis 278*/32124
ne-associated pure red aplasia (PRCA)/Lamivudine-associat 32142

dren/Different rates of CD69, CD25, HLA-DR and CD45RO expre
ted patients/Increased expression in non-stimulated CD8+
duals/Coexpression of and CD28 antigens in T lymphocytes
IV infected individuals/ and CD86 adhesion molecules on cir
stricted CTL induction/ confers and directs and MHC class I
eripheral expansion of CD8 +CD28- lymphocytes in the blood of
nde, Cameroon/CD4+, + cell counts, CD4/CD8 ratio and clinic
sistant strain/CD4 and response within one year after primar
ry populations/Human + T-cell differentiation in acute viral an
etroviral therapy lowers counts toward the normal range/Early
viral activity/Persistent + T lymphocyte activation despite prol
/Distinctive patterns of T cell clonal dominance identified in H
mover of both CD4 and T-cells in HIV-1 infection until end sta
ndent HIV-1-infection of + T cells in vivo/HHV-6-independent
bystander cell death of T cells induced by CD4 crosslinking (
Macrophages-mediated + T-cell killing via CXC-R4/ENV intera
synthesis in CD4+ and + cell subsets during progression of HI
without subunit boost/ + CTL induced in AIDS vaccine evalu
delivery of multiple HIV + cytotoxic T cells epitopes/A polytop
eases circulating naive + T cell counts/Highly active antiretrov
rtoire and reduction of + T cell oligoclonality/Initiation of antir
ag p55 and pol specific + CTL responses early following HIV-1
ars to be mediated by a + cell anti-HIV response/Protection of
apy/Down regulation of + T-cell expansions in HIV patients rec
of CD28 and CD38 by + T cells in HIV infection correlates wit
ssion in non-stimulated + T-cells from HIV infected patients/In
onoclonal expansion of lymphocytes in HIV infection/Benign
erapy normalizes CD4/ ratio in HIV infected patients/Early init
nt of viral load and CD4/ ratio in blood and lymph nodes in pati